Oosterwijk E - Search Results

1

In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.

Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, Boerman OC. Steffens MG, et al. Among authors: oosterwijk e. J Nucl Med. 1999 May;40(5):829-36. J Nucl Med. 1999. PMID: 10319758 Free article.

2

Perfusion of tumor-bearing kidneys as a model for scintigraphic screening of monoclonal antibodies.

van Dijk J, Oosterwijk E, van Kroonenburgh MJ, Jonas U, Fleuren GJ, Pauwels EK, Warnaar SO. van Dijk J, et al. Among authors: oosterwijk e. J Nucl Med. 1988 Jun;29(6):1078-82. J Nucl Med. 1988. PMID: 3373316 Free article.

3

Development and characterization of anti-renal cell carcinoma x antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma.

Kranenborg MH, Boerman OC, Oosterwijk-Wakka JC, de Weijert MC, Corstens FH, Oosterwijk E. Kranenborg MH, et al. Among authors: oosterwijk e, oosterwijk wakka jc. Cancer Res. 1995 Dec 1;55(23 Suppl):5864s-5867s. Cancer Res. 1995. PMID: 7493361

4

Internal image anti-idiotype antibodies related to renal-cell carcinoma-associated antigen G250.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Feb 15;56(4):609-14. doi: 10.1002/ijc.2910560424. Int J Cancer. 1994. PMID: 7509324

5

Radiolabeled monoclonal antibody G250 in renal-cell carcinoma.

Oosterwijk E, Debruyne FM. Oosterwijk E, et al. World J Urol. 1995;13(3):186-90. doi: 10.1007/BF00184877. World J Urol. 1995. PMID: 7550393 Free article. Clinical Trial.

6

The use of monoclonal antibody G250 in the therapy of renal-cell carcinoma.

Oosterwijk E, Debruyne FM, Schalken JA. Oosterwijk E, et al. Semin Oncol. 1995 Feb;22(1):34-41. Semin Oncol. 1995. PMID: 7855618 Review. No abstract available.

7

High energy shock waves induced increase in the local concentration of systemically given TNF-alpha.

Cornel EB, Oosterwijk E, van de Streek JD, Grutters G, Debruyne FM, Schalken JA, Oosterhof GO. Cornel EB, et al. Among authors: oosterwijk e. J Urol. 1994 Dec;152(6 Pt 1):2164-6. doi: 10.1016/s0022-5347(17)32344-3. J Urol. 1994. PMID: 7966708

8

Immunization with anti-idiotype monoclonal antibodies bearing the internal image of the renal-cell carcinoma-associated antigen G250 induces specific cellular immune responses.

Uemura H, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Dec 15;59(6):802-7. doi: 10.1002/ijc.2910590616. Int J Cancer. 1994. PMID: 7989122

9

Vaccination with anti-idiotype antibodies mimicking a renal cell carcinoma-associated antigen induces tumor immunity.

Uemura H, Beniers AJ, Okajima E, Debruyne FM, Oosterwijk E. Uemura H, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Aug 15;58(4):555-61. doi: 10.1002/ijc.2910580418. Int J Cancer. 1994. PMID: 8056452

10

Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.

van Dijk J, Uemura H, Beniers AJ, Peelen WP, Zegveld ST, Fleuren GJ, Warnaar SO, Oosterwijk E. van Dijk J, et al. Among authors: oosterwijk e. Int J Cancer. 1994 Jan 15;56(2):262-8. doi: 10.1002/ijc.2910560220. Int J Cancer. 1994. PMID: 8314310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters